Addresses Big Data Challenges, Integrates and Provides
Analytics for Clinical and Omics Data to Accelerate
Personalized Medicine Initiatives
Redwood Shores, Calif. - January 23, 2012
News Facts
Oracle Health Sciences today announced availability of
Oracle® Health Sciences Omics Data Bank, a molecular data
model, which is part of Oracle Health Sciences
Translational Research Center. The new data model provides
integration and analysis of cross-platform omics data to
support translational research.
Oracle Health Sciences Translational Research Center
enables pharmaceutical and biotech companies, contract
research organizations, as well as academic research
organizations to normalize, aggregate, and analyze data
from numerous internal and external sources, including
clinical systems, lab systems, next-generation sequencing
platforms, and biobanks, to identify new predictive
biomarkers, best practices for diagnosis and treatment, and
more effective personalized therapies.
Oracle Health Sciences Omics Data Bank enables turnkey
integration and analysis of multiple types of molecular
data, including whole genome sequencing and gene expression
data irrespective of the platform used. The omics data
model provides researchers with unprecedented power and
agility in analyzing large molecular data sets from
internal and external sources.
The solution also includes out-of-the-box adapters for
loading customer generated molecular profiling data, as
well as public domain data from sources such as Ensembl,
The Cancer Genome Atlas and Pathway Commons, to further
speed time to value.
Oracle Health Sciences Translational Research Center scales
to support large, global studies incorporating thousands of
whole genome sequences while ensuring appropriate levels of
security and access control.
Oracle Health Sciences Translational Research Center runs
on
Oracle Exadata Database Machine, delivering the extreme
performance required for querying vast data sets.
Supporting Quotes
"The release of Oracle Health Sciences Omics Data Bank
for Oracle Health Sciences Translational Research Center
demonstrates Oracle's continued commitment to making
personalized medicine a reality," said Neil de
Crescenzo, senior vice president and general manager,
Oracle Health Sciences. "Molecular data is a critical
component of any translational medicine initiative, and
Oracle Health Sciences Translational Research Center now
has the power to help researchers address the big data
challenges associated with bioinformatics."
"With the rapidly dropping cost of whole genome
sequencing, the challenge for personalized medicine is
moving from generation of the data to analysis," said
Dr. Brian Druker, M.D., director, Oregon Health & Science
University Knight Cancer Institute. "Oracle
Health Sciences Translational Research Center represents an
important step forward."
"The Inova Translational Medicine Institute (ITMI) is
in the midst of one of the largest genome sequencing
projects ever," said Dr. John Niederhuber, Chief
Executive Officer, Inova Translational Medicine Institute
and former Director of the National Cancer Institute.
"Our goal is to unlock new insights in pre-term
delivery. We hope to identify genomic alternations that
identify high risk patients early in their pregnancy, so
that they may take advantage of therapies designed to delay
pre-term delivery. Working with the outstanding NICU
physicians and nurses at Inova Fairfax Hospital, ITMI
anticipates that our research will enhance our
understanding of the mechanisms that lead to pre-term
delivery. Oracle is uniquely positioned to support the
complete integration of our clinical data with data from
the 1,500 whole genomes sequenced as a part of the project,
providing us with the platform required to perform genomic
analyses, leading to improved patient care through
personalized genomic medicine."
Supporting Resources
Follow
Oracle Health Sciences on Twitter
Join
the Oracle Health Sciences Community on Facebook
Video: Oracle Health
Sciences Translational Research Center
About Oracle
Oracle engineers hardware and software to work together in
the cloud and in your data center. For more
information about Oracle (NASDAQ:ORCL), visit www.oracle.com.
Trademark
Oracle is a registered trademark of Oracle and/or its
affiliates. Other names may be trademarks of their
respective owners.
# # #